Design, Microwave-Assisted Synthesis, Antimicrobial and Anticancer Evaluation, and In Silico Studies of Some 2‑Naphthamide Derivatives as DHFR and VEGFR‑2 Inhibitors

Design, Microwave-Assisted Synthesis, Antimicrobial and Anticancer Evaluation, and In Silico Studies of Some 2‑Naphthamide Derivatives as DHFR and VEGFR‑2 Inhibitors

Bibliographic Details
Main Authors:	Em Canh Pham, Tuyen Ngoc Truong
Format:	Article
Language:	English
Published:	American Chemical Society 2022-09-01
Series:	ACS Omega
Online Access:	https://doi.org/10.1021/acsomega.2c05206

Similar Items

Hybrid Caffeic Acid-Based DHFR Inhibitors as Novel Antimicrobial and Anticancer Agents
by: Renu Sehrawat, et al.
Published: (2024-05-01)

In silico analysis, synthesis and biological evaluation of DHFR inhibitors
by: Chaitali Lad, et al.
Published: (2021-10-01)

DHFR Inhibitors: Reading the Past for Discovering Novel Anticancer Agents
by: Maria Valeria Raimondi, et al.
Published: (2019-03-01)

Albendazole repurposing on VEGFR-2 for possible anticancer application: In-silico analysis
by: Nikita Maruti Gaikwad, et al.
Published: (2023-01-01)

New benzothiazole hybrids as potential VEGFR-2 inhibitors: design, synthesis, anticancer evaluation, and in silico study
by: Mohammad M. Al-Sanea, et al.
Published: (2023-12-01)

Metal-free Borylation of α‑Naphthamides and Phenylacetic Acid Drug
by: Suman Maji, et al.
Published: (2024-09-01)

Novel tetrahydroisoquinolines as DHFR and CDK2 inhibitors: synthesis, characterization, anticancer activity and antioxidant properties
by: Eman M. Sayed, et al.
Published: (2024-02-01)

A Theobromine Derivative with Anticancer Properties Targeting VEGFR‐2: Semisynthesis, in silico and in vitro Studies
by: Prof. Ibrahim H. Eissa, et al.
Published: (2023-10-01)

Design, Synthesis, and Biological Evaluation Studies of Novel Naphthalene-Chalcone Hybrids As Antimicrobial, Anticandidal, Anticancer, and VEGFR‑2 Inhibitors
by: Derya Osmaniye, et al.
Published: (2023-02-01)

Design, Synthesis, In Silico and In Vitro Studies of New Immunomodulatory Anticancer Nicotinamide Derivatives Targeting VEGFR-2
by: Reda G. Yousef, et al.
Published: (2022-06-01)

Design and synthesis of thiazolidine-2,4-diones hybrids with 1,2-dihydroquinolones and 2-oxindoles as potential VEGFR-2 inhibitors: in-vitro anticancer evaluation and in-silico studies
by: Mohammed S. Taghour, et al.
Published: (2022-12-01)

Discovery of sulfonamide-tethered isatin derivatives as novel anticancer agents and VEGFR-2 inhibitors
by: Moataz A. Shaldam, et al.
Published: (2023-12-01)

Novel Anticancer Fused Pyrazole Derivatives as EGFR and VEGFR-2 Dual TK Inhibitors
by: Nashwa M. Saleh, et al.
Published: (2020-01-01)

Novel Benzimidazole–Oxadiazole Derivatives as Anticancer Agents with VEGFR2 Inhibitory Activity: Design, Synthesis, In Vitro Anticancer Evaluation, and In Silico Studies
by: Ulviye Acar Çevik, et al.
Published: (2025-02-01)

Crystal structure of N2-(3-morpholinopropyl)-3-hydroxy-2-naphthamide, C18H22N2O3
by: Crisp G. T., et al.
Published: (1998-04-01)

Synthesis, antibacterial evaluation and in silico studies of novel 2-(benzo[d]thiazol-2-yl)-N-arylacetamides and their derivatives as potential DHFR inhibitors
by: Nadia Hanafy Metwally, et al.
Published: (2025-01-01)

In Silico Analysis of Triamterene as a Potential Dual Inhibitor of VEGFR-2 and c-Met Receptors
by: Stuart Lutimba, et al.
Published: (2024-12-01)

Design and In Silico and In Vitro Evaluations of a Novel Nicotinamide Derivative as a VEGFR-2 Inhibitor
by: Ibrahim H. Eissa, et al.
Published: (2024-01-01)

Discovery of new thiazolidine-2,4-dione derivatives as potential VEGFR-2 inhibitors: In vitro and in silico studies
by: Ibrahim H. Eissa, et al.
Published: (2024-01-01)

Design, Synthesis, and Antimicrobial Evaluation of a New Series of N‑Sulfonamide 2‑Pyridones as Dual Inhibitors of DHPS and DHFR Enzymes
by: Rasha A. Azzam, et al.
Published: (2020-04-01)

Design, Synthesis, Molecular Modeling, and Anticancer Evaluation of New VEGFR-2 Inhibitors Based on the Indolin-2-One Scaffold
by: Mohamed A. Abdelgawad, et al.
Published: (2022-11-01)

Optimization of microwave-assisted biodiesel production from waste catfish using response surface methodology
by: Em Canh Pham, et al.
Published: (2022-11-01)

Potential inhibitors of VEGFR1, VEGFR2, and VEGFR3 developed through Deep Learning for the treatment of Cervical Cancer
by: Anuraj Nayarisseri, et al.
Published: (2024-06-01)

Benzoxazole derivatives as new VEGFR-2 inhibitors and apoptosis inducers: design, synthesis, in silico studies, and antiproliferative evaluation
by: Mohammed S. Taghour, et al.
Published: (2022-12-01)

In Silico Screening of 1,3,4-Thiadiazole Derivatives as Inhibitors of Vascular Endothelial Growth Factor Receptor-2 (VEGFR-2)
by: Steven M. Ewell, et al.
Published: (2024-10-01)

In Vitro Anticancer Activity Screening of Novel Fused Thiophene Derivatives as VEGFR-2/AKT Dual Inhibitors and Apoptosis Inducers
by: Rana M. Abdelnaby, et al.
Published: (2022-06-01)

In Silico and In Vitro Studies for Benzimidazole Anthelmintics Repurposing as VEGFR‑2 Antagonists: Novel Mebendazole-Loaded Mixed Micelles with Enhanced Dissolution and Anticancer Activity
by: Ayman Abo Elmaaty, et al.
Published: (2021-12-01)

Photoactivatable Caged Prodrugs of VEGFR-2 Kinase Inhibitors
by: Boris Pinchuk, et al.
Published: (2016-04-01)

Structural and Dynamics Perspectives on the Binding of Substrate and Inhibitors in Mycobacterium tuberculosis DHFR
by: Pimonluck Sittikornpaiboon, et al.
Published: (2017-09-01)

Novel thienopyrimidine derivatives as dual EGFR and VEGFR-2 inhibitors: design, synthesis, anticancer activity and effect on cell cycle profile
by: Aml E.-S. Mghwary, et al.
Published: (2019-01-01)

Design, synthesis, docking, ADMET studies, and anticancer evaluation of new 3-methylquinoxaline derivatives as VEGFR-2 inhibitors and apoptosis inducers
by: Mohammed M. Alanazi, et al.
Published: (2021-01-01)

Design, synthesis, anticancer evaluation, and molecular modelling studies of novel tolmetin derivatives as potential VEGFR-2 inhibitors and apoptosis inducers
by: Asmaa E. Kassab, et al.
Published: (2021-01-01)

Research Progress of Small Molecule VEGFR/c-Met Inhibitors as Anticancer Agents (2016–Present)
by: Qian Zhang, et al.
Published: (2020-06-01)

New Thiophenyl-pyrazolyl-thiazole Hybrids as DHFR Inhibitors: Design, Synthesis, Antimicrobial Evaluation, Molecular Modeling, and Biodistribution Studies
by: Dina H. Dawood, et al.
Published: (2023-10-01)

Anti-cancer and immunomodulatory evaluation of new nicotinamide derivatives as potential VEGFR-2 inhibitors and apoptosis inducers: in vitro and in silico studies
by: Reda G. Yousef, et al.
Published: (2022-12-01)

New Series of VEGFR-2 Inhibitors and Apoptosis Enhancers: Design, Synthesis and Biological Evaluation
by: Abdallah AE, et al.
Published: (2022-03-01)

Synthesis and Antimicrobial Evaluation of New 1,2,4-Triazolo[1,5‑a]pyrimidine-Based Derivatives as Dual Inhibitors of Bacterial DNA Gyrase and DHFR
by: Lamya H. Al-Wahaibi, et al.
Published: (2024-11-01)

Synthesis, Anticancer Screening of Some Novel Trimethoxy Quinazolines and VEGFR2, EGFR Tyrosine Kinase Inhibitors Assay; Molecular Docking Studies
by: Abdulmalik S. Altamimi, et al.
Published: (2021-05-01)

Discovery of a highly selective VEGFR2 kinase inhibitor CHMFL-VEGFR2-002 as a novel anti-angiogenesis agent
by: Zongru Jiang, et al.
Published: (2020-03-01)

Virtual screening of anticancer activity of chalcones and pyrazolines as potential EGFR, VEGFR, and cytochrome P450 inhibitors
by: Hesti Lina Wiraswati, et al.
Published: (2023-07-01)